Abstract:
A securement device assembly, including an adhesive layer having a top surface and a bottom surface, wherein said adhesive layer includes at least two apertures, a non-adhesive substrate secured to said bottom surface of said adhesive layer to form an integral unit, and a plurality of perforations within said integral unit.

Description:
CROSS REFERENCE TO RELATED APPLICATIONS 
       [0001]    This application claims priority under 35 U.S.C. §120 and 35 U.S.C. §365(c) as a continuation-in-part of PCT International Patent Application No. PCT/US2016/020075, filed Feb. 29, 2016, which application is incorporated herein by reference in its entirety. 
     
    
     FIELD 
       [0002]    The invention relates generally to securement device assemblies, and, more particularly to assemblies that can be used as securement and dressing devices in the medical profession. 
       BACKGROUND 
       [0003]    Securement devices are used in the medical profession to secure needles and catheters inserted within patients to prevent dislodgement, phlebitis, damage to surrounding tissue, and the ingress of bacteria at the insertion site, and damaging surrounding tissue. Medical grade tape can be used as a securement device or to supplement a securement device. Safe and effective securement devices are particularly critical for the treatment of chronic conditions, such as kidney failure, which requires constant dialysis treatment for removing waste from a patient&#39;s blood. For patients receiving routine hemodialysis, for example, an intravenous catheter is one method that may be used to gain access to the blood. Catheter access consists of a plastic catheter with two lumens which is inserted into a large vein to allow large flows of blood to be withdrawn from one lumen, to enter the dialysis circuit, and to be returned via the other lumen. The constant site technique is being increasingly employed, where a blunted needle is inserted in exactly the same site, so as to develop “buttonhole” accesses that may be used repeatedly. However, the skin surrounding a buttonhole access is continually irritated and is susceptible to infection. Since existing securement devices are primarily opaque, healthcare providers are unable to visualize the entire insertion site. Thus, tape application, removal, and reapplication can be cumbersome. 
         [0004]    To expedite hemodialysis which can take hours to complete, efficient blood and dialysate flow rates are desired. To achieve optimal flow rates, needles or catheters often require adjustment, either at the onset of or at some point during treatment. Typically, to adjust a securement device, tape is removed and new tape is applied to and around the site further aggravating the skin. 
         [0005]    Healthcare providers have struggled with providing securement devices that are effective and sterile yet minimally aggravating to patients. 
         [0006]    United States Patent Application Publication No. 2010/0198161 (Propp) discloses a window dressing having an integral anchor. The window dressing disclosed includes a fabric layer having juxtaposed insertion site viewing and anchor member portions. The fabric layer has an adhesive side and an opposite non-adhesive side. The insertion site viewing portion is defined by an opening in the fabric layer. A transparent film layer having an adhesive skin-adhering side and an opposite non-adhesive side is adhered to the fabric layer adhesive side and closes the opening in the fabric layer. The anchor member portion includes a reinforcing structure disposed on the fabric layer and having an adhesive side and an opposite non-adhesive side. The reinforcing structure adhesive side is adhered to the fabric layer non-adhesive side such that the reinforcing structure is on top of the fabric layer. Unfortunately, the Propp reference discloses an assembly that is mostly opaque fabric having only a small opening through which the insertion site may be viewed. Moreover, the Propp reference discloses layers having sides which are either completely coated with adhesive or not coated at all. 
         [0007]    U.S. Pat. No. 4,704,177 (Vaillancourt) discloses a medicator securing device utilizing a thin, transparent plastic film coated on one side with an adhesive and having a border frame at least along three sides. No adhesive is present on the exposed surfaces of the border frame and are available to be grasped so as to provide ready separation of the adhesive surfaces of the facing films when brought together. Unfortunately, the Vaillancourt reference discloses a sheet having sides which are either continuously coated with adhesive or not coated at all. 
         [0008]    A latex-free, hypoallergenic paper tape is available from 3M Corporate Headquarters, 3M Center, St. Paul, Minn. 55144-1000 (3M ID 70200407446; UPC# 30707387075553). However, the paper tape is opaque. 
         [0009]    Therefore, there is a long-felt need for a completely transparent tape assembly having a non-adhesive substrate and an adhesive applied to some portions of the substrate while other portions of the substrate remain without adhesive. There is also a need for a tape assembly that is customizable for different needles or catheters. 
       SUMMARY 
       [0010]    According to aspects illustrated herein, there is provided a securement device assembly, comprising an adhesive layer having a top surface and a bottom surface, wherein said adhesive layer includes at least two apertures, a non-adhesive substrate secured to said bottom surface of said adhesive layer to form an integral unit, and a plurality of perforations within said integral unit. 
         [0011]    According to aspects illustrated herein, there is provided a securement and dressing device assembly, comprising an adhesive layer having a top surface and a bottom surface, wherein said adhesive layer includes at least two apertures, a non-adhesive substrate, comprising at least one absorption element secured to said non-adhesive substrate, and arranged in registration with a first of said apertures, and at least one permeable element secured to said non-adhesive substrate, and arranged in registration with a second of said apertures, wherein said non-adhesive substrate is secured to said bottom surface of said adhesive layer to form an integral unit, and a plurality of perforations arranged within said integral unit. 
         [0012]    According to aspects illustrated herein, there is provided a method for securing a needle assembly to a person using a tape assembly, comprising the steps of inserting said needle assembly into a vessel of said person, said needle assembly comprising a tube connected to a needle and a wing fixedly secured thereto, adhering a first strip of material under said tubing proximate said wing of said needle, wherein said first strip of material has a first end and a second end, folding said first end and said second end of said first strip of material such that said first and second ends traverse said wing of said needle, adhering said first and second ends of said first strip of material to said person, and adhering a second strip of material atop of said wing and said first strip of material. 
         [0013]    According to aspects illustrated herein, there is provided a securement and dressing device assembly, comprising an adhesive layer having a top surface and a bottom surface, wherein said adhesive layer includes at least two apertures, a non-adhesive substrate secured said bottom surface of said adhesive layer to form an integral unit, and a plurality of perforations operatively arranged within said integral unit, said plurality of perforations forming a first portion having a plurality of removable strips and a second portion having at least one absorption element and at least one permeable element. 
         [0014]    According to aspects illustrated herein, there is provided a securement device assembly, comprising a non-adhesive substrate having a first top surface and a first bottom surface, an adhesive layer having a second top surface and a second bottom surface, said adhesive layer secured to said first top surface along said second bottom surface, a plurality of adhesive blockers arranged on the second top surface, wherein the non-adhesive substrate, the adhesive layer, and the plurality of adhesive blockers form an integral unit, and a plurality of perforations within said integral unit separating said integral unit into a plurality of sections. 
         [0015]    The primary object of the invention is to provide a tape assembly which is completely transparent to allow for medical personal to observe a medical procedure. 
         [0016]    A further object of the invention is to provide a tape assembly with adhesive in certain locations to allow for easy adjustment and readjustment of the tape assembly. 
         [0017]    Yet another object of the invention is to provide a transparent tape assembly having a minimal amount of adhesive such that the tape assembly is effective yet minimally abrasive to the skin of a patient. 
         [0018]    Another object of the invention is to provide a tape assembly for securing a needle within a patient&#39;s arm and for dressing the cannulation site after the needle has been removed. 
         [0019]    These and other objects, features, and advantages of the present disclosure will become readily apparent upon a review of the following detailed description of the disclosure, in view of the drawings and appended claims. 
     
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
         [0020]    Various embodiments are disclosed, by way of example only, with reference to the accompanying schematic drawings in which corresponding reference symbols indicate corresponding parts, in which: 
           [0021]      FIG. 1 a    is a top view of the assembly of the present invention; 
           [0022]      FIG. 1 b    is a fragmentary exploded view of a first embodiment of the assembly shown in  FIG. 1   a;    
           [0023]      FIG. 1 c    is a cross-sectional view of the first embodiment of the assembly taken generally along line  1   a - 1   a  in  FIG. 1   a;    
           [0024]      FIG. 2  is a perspective view of a needle within a patient&#39;s arm; 
           [0025]      FIG. 3  is a perspective view of the needle secured to the patient&#39;s arm shown in  FIG. 2  except a transparent strip of the assembly is applied; 
           [0026]      FIG. 4  is a perspective view of the needle secured to the patient&#39;s arm shown in  FIG. 3  except another transparent strip of the assembly is positioned proximate the patient&#39;s arm; 
           [0027]      FIG. 5  is a perspective view of the needle assembly shown in  FIG. 4 , except the transparent strip is further positioned proximate the patient&#39;s arm; 
           [0028]      FIG. 6  is a perspective view of the needle secured to the patient&#39;s arm shown in  FIG. 5  except the transparent strip is adhered to the patent&#39;s arm; 
           [0029]      FIG. 7 a    is a fragmentary exploded view of the assembly shown in  FIG. 1   a;    
           [0030]      FIG. 7 b    is a cross-sectional view of the tape assembly taken generally along line  7   b - 7   b  in  FIG. 1   a;    
           [0031]      FIG. 7 c    is a cross sectional view of the tape assembly taken generally along line  7   c - 7   c  in  FIG. 1   a;    
           [0032]      FIG. 8  is a perspective view of the tape assembly dressed; 
           [0033]      FIG. 9  is a cross sectional view of the dressing of the assembly shown in  FIG. 8  taken generally along line  9 - 9  in  FIG. 8 ; 
           [0034]      FIG. 10 a    is a fragmentary exploded view of a second embodiment of the assembly shown in  FIG. 1 a   ; and, 
           [0035]      FIG. 10 b    is a cross-sectional view of the second embodiment of the assembly taken generally along line  1   a - 1   a  in  FIG. 1   a.    
       
    
    
     DETAILED DESCRIPTION 
       [0036]    At the outset, it should be appreciated that like drawing numbers on different drawing views identify identical, or functionally similar, structural elements. It is to be understood that the claims are not limited to the disclosed aspects. 
         [0037]    Furthermore, it is understood that this disclosure is not limited to the particular methodology, materials, and modifications described and as such may, of course, vary. It is also understood that the terminology used herein is for the purpose of describing particular aspects only, and is not intended to limit the scope of the claims. 
         [0038]    Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this disclosure pertains. It should be understood that any methods, devices, or materials similar or equivalent to those described herein can be used in the practice or testing of the example embodiments. 
         [0039]    It should be appreciated that the term “substantially” is synonymous with terms such as “nearly,” “very nearly,” “about,” “approximately,” “around,” “bordering on,” “close to,” “essentially,” “in the neighborhood of,” “in the vicinity of,” etc., and such terms may be used interchangeably as appearing in the specification and claims. It should be appreciated that the term “proximate” is synonymous with terms such as “nearby,” “close,” “adjacent,” “neighboring,” “immediate,” “adjoining,” etc., and such terms may be used interchangeably as appearing in the specification and claims. The term “approximately” is intended to mean values within ten percent of the specified value. 
         [0040]    Adverting now to the figures,  FIG. 1 a    is a top view of assembly  10 . Assembly  10  broadly includes, from bottom to top, transparent non-adhesive substrate  11 , transparent adhesive layer  12 , and removable layer  13 . Of these three layers, only removable layer  13  is visible from the top view shown in  FIG. 1 a   . When assembled, the bottom side of removable layer  13  is adhered to the top side of transparent adhesive layer  12 , and the top side of transparent non-adhesive substrate  11  is adhered to the bottom side of transparent adhesive layer  12 . Transparent non-adhesive substrate  11  and transparent adhesive layer  12  are arranged such that they remain adhesively joined. Removable layer  13  is arranged such that it is removable from transparent adhesive layer  12  and transparent non-adhesive substrate  11 . 
         [0041]    As shown in  FIG. 1 a   , assembly  10  can include perforations. In a preferred embodiment, perforation lines  20 ,  21 ,  22 ,  23 ,  24 ,  25 ,  26 , and  27  are included to separate assembly  10  into removable sections  31 ,  32 ,  33 ,  34 ,  35 ,  36 ,  38 ,  38 ′,  39 , and  39 ′. It should be appreciated that assembly  10  is divisible into removable sections  31 ,  32 ,  33 ,  34 ,  35 ,  36 ,  38 ,  38 ′,  39 , and  39 ′ while transparent non-adhesive substrate  11 , transparent adhesive layer  12 , and removable layer  13  remain assembled. For example, if removable sections  31 ,  32 , and  33  are separated from removable sections  34 ,  35 ,  36 ,  38 ,  38 ′,  39 , and  39 ′ along perforation line  22 , removable sections  31 ,  32 , and  33  remain joined and include the corresponding portions of transparent non-adhesive substrate  11 , transparent adhesive layer  12 , and removable layer  13 . Using the same example and same circumstances, sections  34 ,  35 ,  36 ,  38 ,  38 ′,  39 , and  39 ′ remain joined and include the corresponding portions of transparent non-adhesive substrate  11 , transparent adhesive layer  12 , and removable layer  13 . 
         [0042]    Removable layer  13  includes apertures  40 ,  41 ,  42 ,  43 ,  44 ,  45 ,  46 , and  47 , and transparent adhesive layer  12  includes apertures  50 ,  51 ,  52 ,  53 ,  54 ,  55 ,  56 , and  57 . Said apertures represent the absence of material within removable layer  13  and transparent adhesive layer  12 , respectively.  FIG. 1 a    shows removable layer  13  apertures  40 ,  41 ,  42 ,  43 ,  44 ,  45 ,  46 , and  47 . Transparent adhesive layer  12  apertures  50 ,  51 ,  52 ,  53 ,  54 ,  55 ,  56 , and  57 , are aligned directly below, and are identical in size to, removable layer  13  apertures  40 ,  41 ,  42 ,  43 ,  44 ,  45 ,  46 , and  47 , respectively. In one embodiment, apertures are cut into removable layer  13  and transparent adhesive layer  12  after they have been secured together, but before transparent non-adhesive substrate  11  is assembled. This ensures that apertures  40 ,  41 ,  42 ,  43 ,  44 ,  45 ,  46 , and  47  are precisely aligned with, and identical in size to, apertures  50 ,  51 ,  52 ,  53 ,  54 ,  55 ,  56 , and  57 , respectively. Thus, describing the dimensions and orientation of removable layer  13  apertures sufficiently describes the respective transparent adhesive layer  12  apertures. Aperture  40  extends from perforation line  20  to perforation line  24  and spans removable sections  32 ,  33 ,  34 , and  35  of assembly  10 . Aperture  43  is substantially similar to aperture  40 , as it also extends from perforation line  20  to perforation line  24  and spans removable sections  32 ,  33 ,  34 , and  35 . In a preferred embodiment, apertures  40  and  43  are substantially parallel. Apertures  41  and  42  are located between apertures  40  and  43 . Aperture  41  extends from perforation line  21  to perforation line  23  and spans removable sections  33  and  34 . Aperture  42  is substantially similar to aperture  41 , as it also extends from perforation line  21  to perforation line  23  and spans removable sections  43  and  44 . In a preferred embodiment, apertures  41  and  42  are substantially parallel. 
         [0043]    Also in a preferred embodiment, apertures  40 ,  41 ,  42 , and  43  are substantially parallel. It is important to note, however, that perforation lines  20 ,  21 ,  22 ,  23 ,  24 ,  25 ,  26 , and  27  and apertures  40 ,  41 ,  42 , and  43  do not need to be parallel and can be of any shape. For example, perforation lines  20 ,  21 ,  22 ,  23 ,  24 ,  25 ,  26 , and  27  could be represented by lines with an oscillating wave pattern and apertures  40 ,  41 ,  42 , and  43  could be of any shape such as an oval or circle. 
         [0044]      FIG. 1 b    is a fragmentary exploded view of a first embodiment of assembly  10 . Subassembly  10 A is the adhesive strip portion of assembly  10 . Subassembly  10 A includes removable sections  31 ,  32 ,  33 ,  34 ,  35 , and  36 , which can be separated from removable sections  38 ,  38 ′,  39 , and  39 ′ along perforation line  25 . Also included in subassembly  10 A are perforation lines  20 ,  21 ,  22 ,  23 , and  24 . Removable sections  31 ,  32 ,  33 ,  34 ,  35 , and  36  each include respective portions of transparent non-adhesive substrate  11 , transparent adhesive layer  12 , and removable layer  13 . As shown in  FIG. 1 b   , transparent adhesive layer  12  has adhesive sections  31 A,  32 A,  32 B,  32 C,  33 A,  33 B,  33 C,  33 D,  33 E,  34 A,  34 B,  34 C,  34 D,  34 E,  35 A,  35 B,  35 C, and  36 A. Transparent adhesive layer  12  also has apertures  50 ,  51 ,  52 , and  53 , which are identical in dimension to, and are precisely aligned with, removable layer  13  apertures  40 ,  41 ,  42 , and  43 , respectively. Said apertures represent the absence of material within transparent adhesive layer  12  and removable layer  13 , respectively. Removable sections  31 ,  32 , and  33  have substantially similar adhesive sections to that of removable sections  36 ,  35 , and  34 , respectively, as assembly  10  is designed to secure two needles. It should be appreciated that transparent adhesive layer  12  is comparable to double-sided adhesive tape in that it has adhesive on both its bottom surface, to which transparent non-adhesive substrate  11  is secured, and also its top surface, to which removable layer  13  secured. In one embodiment, transparent adhesive layer  12  is a double-sided adhesive tape, such as 3M™ 1577 Two in One Double Coated Tape, consisting of a transparent polyester backing, coated on both sides with a hypoallergenic, pressure sensitive, synthetic rubber based adhesive on the face side and a acrylate adhesive on the linear side. To protect the adhesive coating, 3M™ 1577 Double Coated Tape is supplied with silicone treated, bleached Kraft-Glassine paper liners assembled to both surfaces. After apertures are cut into the double-sided adhesive tape, the bottom surface liner is removed and the tape&#39;s exposed adhesive surface is secured atop transparent non-adhesive substrate  11 . The top surface liner remains assembled as removable layer  13 . In a preferred embodiment, removable layer  13  is a translucent. It is important to note that both adhesive side of 3M™ 1577 Double Coated Tape have different adhesive strengths when compared to one another. The synthetic rubber adhesive has greater adhesive strength that the acrylate adhesive. This is to aid in the removal of the tape from a patient&#39;s skin when treatment is completed and to reduce the amount of irritation on a patient&#39;s skin from the tape. In another embodiment, transparent adhesive layer  12  is a medical adhesive transfer tape, such as 3M™ 1504XL Hi-Tack Transfer Adhesive, consisting of a synthetic rubber-based adhesive supplied in tape form on an extended two-sided siliconized white paper release liner. It should be appreciated, however, that the top surface liner of double-sided adhesive tape and adhesive transfer tape will contain removable layer  13  apertures  40 ,  41 ,  42 , and  43 . Apertures  40 ,  41 ,  42 , and  43  can be eliminated to promote the easy removal of removable layer  13  after assembly  10  is divided into individual removable sections. Thus, in another embodiment, after the bottom adhesive surface of transparent adhesive layer  12  is secured atop transparent non-adhesive substrate  11 , the top surface liner containing apertures  40 ,  41 ,  42 , and  43  is removed. Removable layer  13 , a single continuous liner substantially identical in dimension to transparent non-adhesive substrate  11 , is then secured atop transparent adhesive layer  12 . In yet another embodiment, transparent adhesive layer  12  is adhesive applied directly atop transparent non-adhesive substrate  11  at the locations shown in  FIG. 1 b   . Any suitable method of applying the adhesive, such as spraying, may be used. In a preferred embodiment, transparent non-adhesive substrate  11  is made of polyester, however, any suitable alternative, such as ethylene vinyl acetate (EVA) or polypropylene, can be used. Also in a preferred embodiment, removable layer  13  is silicone release paper operatively arranged to be removable from transparent adhesive layer  12  while preserving the adhesive top surface of transparent adhesive layer  12 . However, removable layer  13  can be any suitable alternative. Moreover, assembly  10  is arranged to be subdivided into corresponding removable sections before detachment of removable layer  13 . Removable layer  13  maintains the adhesive strength and sterility, and should be removed immediately before application to prevent contamination. 
         [0045]    Assembly  10  further comprises perforated elements  60  and  61  and fabric elements  70  and  71 . As shown in  FIG. 1 a   , perforated elements  60  and  61  are positioned within removable sections  38  and  38 ′ of assembly  10 , respectively. Fabric elements  70  and  71  are positioned within removable sections  39  and  39 ′ of assembly  10 , respectively. Subassembly  10 B comprises removable sections  38 ,  38 ′,  39 , and  39 ′, which can be separated from subassembly  10 A, comprising removable sections  31 ,  32 ,  33 ,  34 ,  35 , and  36 , along perforation line  25 . Subassembly  10 B also comprises perforation lines  26  and  27 . Removable sections  38  and  38 ′ can be separated from removable sections  39  and  39 ′, respectively, along perforation line  26 . Removable sections  38  and  39  can be separated from removable sections  38 ′ and  39 ′, respectively, along perforation line  27 . 
         [0046]      FIG. 1 c    shows a cross-sectional view of a first example embodiment of assembly  10  taken generally along line  1   c - 1   c  shown in  FIG. 1 a   . Assembly  10  comprises, from bottom to top, transparent non-adhesive substrate  11 , transparent adhesive layer  12 , and removable layer  13 . As shown in  FIG. 1 c   , transparent adhesive layer  12  has a width which is smaller than the width of transparent non-adhesive substrate  11  to ensure that removable sections do not have adhesive on flaps. This allows attendants to easily grasp removable sections to readjust during use on patient&#39;s arm  1  without removing their gloves. Substantially similar flaps occur on every removable section of assembly  10 . Removable section  31  contains flaps  31 B and  31 C, removable section  32  contains flaps  32 D and  32 E, removable section  33  contains flaps  33 F and  33 G, removable section  34  contains flaps  34 F and  34 G, removable section  35  contains flaps  35 D and  35 E, and removable section  36  contains flaps  36 B and  36 C. Additionally,  FIG. 1 c    shows that removable layer  13  apertures  40 ,  41 ,  42 , and  43  are aligned with transparent adhesive layer  12  apertures  50 ,  51 ,  52 , and  53 , respectively. In one embodiment, apertures are cut into removable layer  13  and transparent adhesive layer  12  before transparent non-adhesive substrate  11  is assembled, but after transparent adhesive layer  12  and removable layer  13  are secured together. This ensures that apertures  40 ,  41 ,  42 , and  43  are properly aligned with apertures  50 ,  51 ,  52 , and  53 , respectively. Transparent adhesive layer  12  is secured to transparent non-adhesive substrate  11  via adhesive arranged on the bottom surface of transparent adhesive layer  12 . 
         [0047]      FIG. 2  is a perspective view of patient&#39;s arm  1  with needle  2  inserted into either a vein or artery, depending on the insertion requirements of the procedure being performed. Also shown in  FIG. 2 , needle  2  contains wings  4  and tube  3 . Typically, infusion needles contain wings to ensure a firm grip during placement. Winged infusion needles often contain flexible wings that can be squeezed together during placement. Once the needle has been inserted, the wings are folded down onto the skin and adhesive tape is placed over the wings. The flexible wings form to the contours of the patient&#39;s arm to ensure maximum surface contact, providing surface friction. However, without added pressure or adhesive means, needle  2  will dislodge from patient&#39;s arm  1 .  FIG. 2  shows needle  2  with wings  4  secured in patient&#39;s arm  1  by needle  2  only. This arrangement is not suitable. In order to secure needle  2 , an attendant must hold needle  2  in patient&#39;s arm  1  by applying pressure to wings  4 . This application technique is dangerous because holding needle  2  within patient&#39;s arm  1  could place additional stress on the injection site, which can cause the patient extreme discomfort and may even cause damage to a vein or artery in the event that needle  2  shifts within patient&#39;s arm  1 . 
         [0048]      FIG. 3  is a perspective view of needle  2  inserted in patient&#39;s arm  1  and secured with removable section  32 . As shown in  FIG. 3 , removable section  32  is positioned substantially perpendicular to inserted needle  2 , with transparent adhesive layer  12  directed toward patient&#39;s arm  1 . Removable section  32  comprises adhesive sections  32 A,  32 B, and  32 C with adhesive section  32 B securing wings  4  of needle  2 . This prevents internal blood pressure from dislodging needle  2  from arm  1 . During needle insertion procedures, an attendant removes adhesive strips along perforation lines and applies them to patient&#39;s arm  1 . Also shown in  FIG. 3  are flaps  32 D and  32 E, and transparent adhesive layer  12  apertures  50  and  53 . As shown, transparent adhesive layer  12  does not extend to non-adhesive flaps  32 D and  32 E, which promotes easy readjustment of adhesive strip  32 . 
         [0049]      FIG. 4  is a perspective view of needle  2  inserted in patient&#39;s arm  1  with removable section  32  securing wings  4  of needle  2 . Also shown in  FIG. 4  is the application of removable section  33 , which is positioned proximate patient&#39;s arm  1 . Removable section  33  comprises adhesive sections  33 A,  33 B,  33 C,  33 D, and  33 E with adhesive section  33 C securing removable section  33  to tube  3  of needle  2 . Removable section  33  is positioned substantially perpendicular to tube  3 , with transparent adhesive layer  12  directed away from patient&#39;s arm  1 . Adhesive section  33 C is positioned on the underside of tube  3 , opposite the side of tube  3  on which adhesive section  32 B is positioned on. An attendant would release removable section  33  from assembly  10  after already positioning removable section  32  on patient&#39;s arm  1 . An attendant would then position removable section  33  on the underside of tube  3  and position adhesive strip  33  in an appropriate location before applying adhesive section  33 C to tube  3 . 
         [0050]      FIGS. 5 and 6  are perspective views of needle  2  inserted in patient&#39;s arm  1  with adhesive strip  32  securing wings  4  of needle  2  and adhesive strip  33  securing tube  3  of needle  2 . As shown in  FIG. 5 , after an attendant has positioned adhesive section  33 C on tube  3 , the two distal ends of removable section  33  are positioned around tube  3  and secured on top of adhesive strip  32  forming a chevron shape. It is important to note, however, that removable section  33  can be positioned on a patient&#39;s arm  1  to form the chevron shape prior to the securement of removable section  32  on wings  4  of needle  2 . The orientation and securement of removable sections  32  and  33  is an extremely important factor for ensuring securement of needle  2  within patient&#39;s arm  1 . The orientation of removable section  33  under tube  3  prevents rotation of needle  2  within patient&#39;s arm  1  during treatment. The placement of the distal ends of removable section  33  provides force that pulls needle  2  forward, into patient&#39;s arm  1 , to prevent internal pressure from dislodging needle  2  from patient&#39;s arm  1 .  FIG. 6  shows a preferred embodiment of the positioning of adhesive strips  32  and  33  applied proximate patient&#39;s arm  1  and needle  2  inserted therein. However, the positioning of removable section  33  on tube  3 , the force applied to needle  2  by removable section  33 , and the distance with which the distal ends of removable section  33  are spaced apart proximate needle  2  are based on the procedure being performed and the patient&#39;s physical characteristics. In a preferred embodiment, removable section  33  would have distal ends positioned in a wide arrangement for a high pressure injection site such as for an artery to ensure needle  2  is fully secured within arm  1 . However, if adjustment of needle  2  is necessary, an attendant can grasp removable section  33  at flaps  33 F and  33 G and reposition the distal ends of adhesive strip  33  in the appropriate locations to ensure proper securement of needle  2  and to maximize patient comfort. 
         [0051]      FIG. 7 a    shows an exploded perspective view of subassembly  10 B. Subassembly  10 B is the portion of assembly  10  that includes removable sections  38 ,  38 ′,  39 , and  39 ′. Subassembly  10 B broadly includes, from bottom to top, transparent non-adhesive substrate  11 , transparent adhesive layer  12 , and removable layer  13 . Assembly  10  is arranged such that transparent non-adhesive substrate  11  and transparent adhesive layer  12  remain adhesively bonded while removable layer  13  is removed from transparent adhesive layer  12 . In a preferred embodiment, transparent non-adhesive substrate  11  is made of polypropylene. Also In a preferred embodiment, removable layer  13  is silicone release paper operatively arranged to be removable from transparent adhesive layer  12  while preserving the adhesive qualities of transparent adhesive layer  12 . However, removable layer  13  can be any suitable alternative. Moreover, assembly  10  is arranged to be subdivided into its corresponding removable sections before removable layer  13  is removed from transparent adhesive layer  12 . 
         [0052]    As shown in  FIG. 1 a   , assembly  10  includes perforation lines to separate assembly  10  into removable sections  38 ,  38 ′,  39 , and  39 ′. In a preferred embodiment, assembly  10  includes perforation lines  26  and  27 . Perforation line  26  separates removable sections  38  and  38 ′ from removable sections  39  and  39 ′, respectively. Perforation line  27  is positioned substantially perpendicular to perforation line  26 , and separates removable sections  38  and  39  from removable sections  38 ′ and  39 ′, respectively. It should be appreciated that assembly  10  is divisible into removable sections  38 ,  38 ′,  39 , and  39 ′ while transparent non-adhesive substrate  11 , transparent adhesive layer  12 , and removable layer  13  remain assembled. Removable sections  38  and  38 ′ are identical and removable sections  39  and  39 ′ are identical, as assembly  10  is designed to secure two needles. Upon removal of each needle, perforated elements  60  and  61  and fabric elements  70  and  71  promote clotting and dressing at the injection sites. 
         [0053]    As shown in  FIG. 7 a   , removable sections  38  and  38 ′ include corresponding portions of removable layer  13 , adhesive sections  38 A and  38 A′ of transparent adhesive layer  12 , and perforated elements  60  and  61  and corresponding portions of transparent non-adhesive substrate  11 , respectively. Perforated elements  60  and  61  are located within corresponding portions  38  and  38 ′ of transparent non-adhesive substrate  11 , respectively. Removable sections  39  and  39 ′ include corresponding portions of removable layer  13 , adhesive sections  39 A and  39 A′ of transparent adhesive layer  12 , and fabric elements  70  and  71  and corresponding portions of transparent non-adhesive substrate  11 , respectively. Fabric elements  70  and  71  are located within corresponding portions  39  and  39 ′ of transparent non-adhesive substrate  11 , respectively. In a preferred embodiment, perforated elements  60  and  61  and fabric elements  70  and  71  are rectangular, with perforated elements  60  and  61  having substantially identical dimensions and fabric elements  70  and  71  having substantially identical dimensions. However, the shape and dimensions of perforated elements  60  and  61  and fabric elements  70  and  71  can be varied. It should be appreciated that transparent adhesive layer  12  is comparable to double-sided tape in that it is adhesive on its bottom surface, to which transparent non-adhesive substrate  11  is attached, and also on its top surface, to which removable layer  13  is attached. Additionally, in a preferred embodiment the perforations of perforated elements  60  and  61  are cuts made into transparent non-adhesive substrate  11  in such a way that they do not have frayed edges such as a stamped out circle. Instead the perforations are cuts made in a ‘+’ shape to ensure material can pass through perforated elements  60  and  61 . It should be appreciated, however, that the use of different perforation styles is possible and to be considered within the scope of the claimed invention. 
         [0054]    Removable layer  13  includes apertures  44 ,  45 ,  46 , and  47  and transparent adhesive layer  12  includes apertures  54 ,  55 ,  56 , and  57 . Said apertures represent the absence of material within removable layer  13  and transparent adhesive layer  12 , respectively. Apertures  44  and  54  and apertures  45  and  55  are located within removable sections  38  and  38 ′, respectively. Apertures  46  and  56  and apertures  47  and  57  are located within removable sections  39  and  39 ′, respectively. In a preferred embodiment, apertures and elements are rectangular shaped, with apertures  44 ,  45 ,  54 , and  55  and perforated elements  60  and  61  having substantially identical dimensions, and apertures  46 ,  47 ,  56 , and  57  and fabric elements  70  and  71  having substantially identical dimensions. It should be appreciated, however, that the use of different shapes for apertures and corresponding elements is possible and to be considered within the claimed invention. Also in a preferred embodiment, apertures  44 ,  45 ,  54 , and  55  of removable sections  38  and  38 ′ and apertures  46 ,  47 ,  56 , and  57  of removable sections  39  and  39 ′ are fully contained within the boundaries set by perforation lines  26  and  27 . This ensures that when removable layer  13  is removed from transparent adhesive layer  12 , an adhesive border completely surrounds perforated elements  60  and  61  and fabric elements  70  and  71 . As shown in  FIG. 7 a   , perforated elements  60  and  61  will have adhesive borders provided by adhesive sections  38 A and  38 A′, respectively, and fabric elements  70  and  71  will have adhesive borders provided by adhesive sections  39 A and  39 A′, respectively. 
         [0055]    When assembling transparent non-adhesive substrate  11 , perforated elements  60  and  61  must be precisely aligned with transparent adhesive layer  12  apertures  54  and  55 , respectively, and fabric elements  70  and  71  must be precisely aligned with transparent adhesive layer  12  apertures  56  and  57 , respectively. As previously discussed, apertures are created after the bottom surface of removable layer  13  is secured to the top surface of transparent adhesive layer  12 . This ensures that removable layer  13  apertures  44 ,  45 ,  46 , and  47  are precisely aligned with transparent adhesive layer  12  apertures  54 ,  55 ,  56 , and  57 , respectively. To expedite the process of making the invention, assembly  10  is designed so that transparent non-adhesive substrate  11  and removable layer  13  have substantially identical exterior dimensions, and the dimensions and location of apertures  44 ,  45 ,  46 , and  47  within removable layer  13  are substantially identical to the dimensions and location of elements  60 ,  61 ,  70 , and  71  within transparent non-adhesive substrate  11 , respectively. The top surface of transparent non-adhesive substrate  11  is positioned about the bottom surface of transparent adhesive layer  12  so edges of transparent non-adhesive substrate  11  are precisely aligned with edges of removable layer  13 , respectively. Transparent non-adhesive substrate  11  is secured to the bottom surface of transparent adhesive layer  12 , ensuring that transparent non-adhesive substrate  11  elements  60 ,  61 ,  70 , and  71  are aligned with transparent adhesive layer  12  apertures  54 ,  55 ,  56 , and  57 , respectively. Also in a preferred embodiment, apertures  46 ,  47 ,  56 , and  57  have smaller dimensions than apertures  44 ,  45 ,  54 , and  55  to ensure that when applied to patient&#39;s arm  1 , fabric elements  70  and  71  can be completely covered by perforated elements  60  and  61 , respectively. 
         [0056]      FIGS. 7 b  and 7 c    show cross-sectional views of assembly  10  taken generally along lines  7   b - 7   b  and  7   c - 7   c  shown in  FIG. 1 a   . As shown in  FIG. 7 b   , transparent adhesive layer  12  has dimensions which are smaller than transparent non-adhesive substrate  11  to ensure that removable sections  38  and  38 ′ do not have adhesive on flaps  38 B and  38 C, or flaps  38 B′ and  38 C′, respectively. Similarly, as shown in  FIG. 7 c   , removable sections  39  and  39 ′ have no adhesive on flaps  39 B and  39 C, or  39 B′ and  39 C′, respectively. This lack of adhesive on flaps allows an attendant to easily grasp removable sections  38 ,  38 ′,  39 , and  39 ′ to readjust during use on patient&#39;s arm  1  without removing their gloves. Additionally, it can be seen that apertures  44 ,  45 ,  46 , and  47  of removable layer  13  are aligned with apertures  54 ,  55 ,  56 , and  57  of transparent adhesive layer  12 , respectively. In a preferred embodiment, apertures are cut into removable layer  13  and transparent adhesive layer  12  before transparent non-adhesive substrate  11  is assembled, but while transparent adhesive layer  12  and removable layer  13  are secured together to ensure that apertures are properly aligned. 
         [0057]      FIG. 8  is a perspective view of patient&#39;s arm  1  properly bandaged.  FIG. 9  is a cross-sectional view of patient&#39;s arm  1  properly bandaged taken along line  9 - 9  in  FIG. 8 . After needle  2  is removed from patient&#39;s arm  1 , the injection site must be covered to stop excessive bleeding. Using removable sections  38  and  39  of subassembly  10 B, the injection site is first covered with removable section  39 , containing fabric element  70 . Removable section  39  is then covered with removable section  38 , containing perforated element  60 . Hemostasis element  80  is placed on top of perforated element  60  to reintroduce nutrients into the patient&#39;s blood stream. Hemostasis element  80  contains a substance that not only aids in the clotting of blood at the injection site, but also releases vital minerals and nutrients into the patient&#39;s blood stream. In a preferred embodiment, hemostasis element  80  is a potato-based mixture used to replenish a patient&#39;s calcium and potassium levels, which could be depleted during a procedure. It should be appreciated, however, that other types of substances can be used within hemostasis element  80  and are considered to be within the scope of the invention as claimed. For example, a substance which utilizes Icelandic shrimp shells can be used to promote blood clotting due to the presence of the natural mineral chitosan within the shells. Certain types of rare earth patches and minerals, including zeolite and kaolinite, when properly prepared can have similar hemostatic effects which can be utilized through this invention. Additionally, a black pepper-based, or cayenne pepper-based, substance could be used to promote blood clotting. Once hemostasis element  80  is placed on top of perforated element  60 , removable section  31  is placed over the top of hemostasis element  80  to secure it until blood clotting occurs. Assembly  10  is designed for two uses, and includes enough fabric elements, perforated elements, and adhesive sections to support securement of two injected needles and promote clotting and dressing of the injection site after the needles are removed. 
         [0058]    In another embodiment, removable section  39  containing fabric element  70  and hemostasis element  80  can be combined by putting hemostat products within fabric element  70 . In a preferred embodiment, fabric element  70  would be a gauze pad which contained a surgical hemostat such as Vitagel™. Vitagel™ includes the biological component thrombin, an enzyme that assists in the clotting of blood when conventional means fail or are impractical. This would allow the hemostasis element  80  to be directly applied to a patient&#39;s skin where a needle was used and clot the blood faster than traditional means. Additionally, assembly  10  is sterilized after assembly of each component to ensure infection does not spread to a patient. The methods for sterilizing assembly  10  include, but are not limited to, gamma ray, x-ray, and electron beam sterilization. 
         [0059]      FIG. 10 a    and  FIG. 10 b    are a fragmentary exploded view and a cross-sectional view of a second embodiment of the assembly, respectively. In the second example embodiment of assembly  10 , transparent adhesive layer  12  does not contain apertures  50 ,  51 ,  52 , and  53 . Instead, transparent adhesive layer  12  completely covers transparent non-adhesive substrate  11  except for non-adhesive flaps  31 B,  31 C,  32 D,  32 E,  33 F,  33 G,  34 F,  34 G,  35 D,  35 E,  36 B, and  36 C. Adhesive blockers  90 ,  91 ,  92 , and  93  are operatively arranged on transparent adhesive layer  12 . The placement of adhesive blockers  90 ,  91 ,  92 , and  93  creates adhesive sections  31 A,  32 A,  32 B,  32 C,  33 A,  33 B,  33 C,  33 D,  33 E,  34 A,  34 B,  34 C,  34 D,  34 E,  35 A,  35 B,  35 C, and  36 A and non-adhesive sections  90 A,  91 A,  92 A, and  93 A covered by adhesive blockers  90 ,  91 ,  92 , and  93 . The addition of adhesive blockers  90 ,  91 ,  92 , and  93  does not alter the function of the second embodiment of assembly  10  when compared to the first embodiment of assembly  10 . 
         [0060]    It will be appreciated that various aspects of the disclosure above and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or applications. Various presently unforeseen or unanticipated alternatives, modifications, variations, or improvements therein may be subsequently made by those skilled in the art which are also intended to be encompassed by the following claims. 
       REFERENCE NUMERALS 
       [0000]    
       
           1  patient&#39;s arm 
           2  needle 
           3  tube 
           4  wings 
           10  assembly 
           10 A subassembly 
           10 B subassembly 
           11  transparent non-adhesive substrate 
           12  transparent adhesive layer 
           13  removable layer 
           20  perforation line 
           21  perforation line 
           22  perforation line 
           23  perforation line 
           24  perforation line 
           25  perforation line 
           26  perforation line 
           27  perforation line 
           31  removable section 
           31 A adhesive section 
           31 B non-adhesive flap 
           31 C non-adhesive flap 
           32  removable section 
           32 A adhesive section 
           32 B adhesive section 
           32 C adhesive section 
           32 D non-adhesive flap 
           32 E non-adhesive flap 
           33  removable section 
           33 A adhesive section 
           33 B adhesive section 
           33 C adhesive section 
           33 D adhesive section 
           33 E adhesive section 
           33 F non-adhesive flap 
           33 G non-adhesive flap 
           34  removable section 
           34 A adhesive section 
           34 B adhesive section 
           34 C adhesive section 
           34 D adhesive section 
           34 E adhesive section 
           34 F non-adhesive flap 
           34 G non-adhesive flap 
           35  removable section 
           35 A adhesive section 
           35 B adhesive section 
           35 C adhesive section 
           35 D non-adhesive flap 
           35 E non-adhesive flap 
           36  removable section 
           36 A adhesive section 
           36 B non-adhesive flap 
           36 C non-adhesive flap 
           38  removable section 
           38 A adhesive section 
           38 B non-adhesive flap 
           38 C non-adhesive flap 
           38 ′ removable section 
           38 A′ adhesive section 
           38 B′ non-adhesive flap 
           38 C′ non-adhesive flap 
           39  removable section 
           39 A adhesive section 
           39 B non-adhesive flap 
           39 C non-adhesive flap 
           39 ′ removable section 
           39 A′ adhesive section 
           39 B′ non-adhesive flap 
           39 C′ non-adhesive flap 
           40  aperture 
           41  aperture 
           42  aperture 
           43  aperture 
           44  aperture 
           45  aperture 
           46  aperture 
           47  aperture 
           50  aperture 
           51  aperture 
           52  aperture 
           53  aperture 
           54  aperture 
           55  aperture 
           56  aperture 
           57  aperture 
           60  perforated element 
           61  perforated element 
           70  fabric element 
           71  fabric element 
           80  hemostasis element 
           90  adhesive blocker 
           91  adhesive blocker 
           92  adhesive blocker 
           93  adhesive blocker 
           90 A non-adhesive section 
           91 A non-adhesive section 
           92 A non-adhesive section 
           93 A non-adhesive section